Colon Polyps clinical trials at UCLA
2 in progress, 1 open to eligible people
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps
open to eligible people ages 21 years and up
This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.
Los Angeles, California
Prevention of Colorectal Cancer Through Multiomics Blood Testing
Sorry, in progress, not accepting new patients
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
Los Angeles, California and other locations
Our lead scientists for Colon Polyps research studies include Folasade P May.
Last updated: